Table 2.
Percent
conversion at HIS4 ± SE (events/total tetrads)
|
||||
---|---|---|---|---|
Leu+ Lys− | Leu− Lys− | Leu+ Lys+ | Leu− Lys+ | |
Ade+ | ||||
GCN4/GCN4 | 27% ± 1.7*‡ (195/719) | 21% ± 1.7*§ (126/588) | 19% ± 1.5†‡ (127/682) | 13% ± 1.5†§ (72/534) |
Δgcn4/Δgcn4 | 12% ± 1.9¶ (37/300) | 10% ± 1.8¶ (28/274) | 13% ± 1.9¶ (40/314) | 10% ± 1.7 (33/313) |
GCN4–URA3–GCN4/GCN4 | ND | ND | ND | 13 ± 2.4 (25/191) |
GCN4c–URA3–GCN4/GCN4 | ND | ND | ND | 48 ± 2.1‖ (94/197) |
Ade−** | ||||
GCN4/GCN4 | 40% ± 3.5 (78/196) | 37% ± 3.6 (64/175) | ND | 37% ± 3.6 (69/185) |
Δgcn4/Δgcn4¶ | 29% ± 3.4 (52/180) | 23% ± 3.1 (42/181) | ND | 23% ± 3.6 (32/140) |
ND, not determined.
Prototrophy for leucine elevates conversion frequency significantly in lysine auxotrophs.
Prototrophy for leucine elevates conversion frequency significantly in lysine prototrophs.
Auxotrophy for lysine elevates conversion frequency significantly in leucine prototrophs.
Auxotrophy for lysine elevates conversion frequency significantly in leucine auxotrophs.
Conversion frequency is significantly lower in Δgcn4 strains than in GCN4.
Constitutive expression of Gcn4p elevates conversion frequencies significantly.
Auxotrophy for adenine elevates conversion frequency significantly (independently of phenotype for leucine or lysine).